Investors continue to fund clinical intelligence and precision medicine startups at a rapid clip.
Yes, but: Epic's entrance into the space could considerably erode their moats.
Investors continue to fund clinical intelligence and precision medicine startups at a rapid clip.
Yes, but: Epic's entrance into the space could considerably erode their moats.
